CEL-SCI Corp (CVM.A)

CVM.A on American Stock Exchange

1.20USD
11 Jul 2014
Price Change (% chg)

$0.02 (+1.69%)
Prev Close
$1.18
Open
$1.19
Day's High
$1.26
Day's Low
$1.19
Volume
27,686
Avg. Vol
62,271
52-wk High
$2.75
52-wk Low
$0.54

CVM.A

Chart for CVM.A

About

CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1... (more)

Overall

Beta: 1.57
Market Cap (Mil.): $78.51
Shares Outstanding (Mil.): 65.97
Dividend: --
Yield (%): --

Financials

  CVM.A Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -0.55 -- --
ROI: -135.84 -0.70 18.27
ROE: -264.78 -1.57 19.16
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $30.07 +0.07
Johnson & Johnson (JNJ.N) $105.10 -0.70
Novartis AG (NOVN.VX) CHF79.60 -0.05
Merck & Co., Inc. (MRK.N) $58.44 -0.14
Roche Holding Ltd. (ROG.VX) CHF262.70 +0.50
Sanofi SA (SASY.PA) €75.81 +0.11
Amgen, Inc. (AMGN.OQ) $119.77 +0.82
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $11.73 +0.30
Seattle Genetics, Inc. (SGEN.OQ) $37.40 +1.07

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks